As part of its strategic transformation into a CDMO (Contract Development and Manufacturing Organisation) for medical devices and complex pharmaceutical drug delivery systems, Sanner announces a management change.
Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies.
UST, a digital transformation solutions company, has partnered with ThinkBio.Ai, an AI-powered solutions provider for biopharmaceutical and healthcare organisations.
Orchestra BioMed Holdings has announced that the company has secured $70 million in new capital from Ligand Pharmaceuticals Incorporated and Medtronic to advance its late-stage partnered cardiology programs.
Polpharma Biologics announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialisation of PB016.
After Identiv announced it's partnership with Novanta to streamline adoption of RFID solutions for healthcare and medical device OEMs, European Pharmaceutical Manufacturer spoke to Deepak Prakash, vice president of healthcare at Identiv.
Everest Medicines has announced that the supplemental application for the production expansion of NEFECON has been officially approved by China’s National Medical Products Administration (NMPA).
Antibodies.com, a provider of biological reagents for life science researchers, has announced the expansion of its UK headquarters with a move to Cambridge Technopark to accommodate the Company’s rapid growth.
Almac Group has announced the official opening of new GMP-qualified analytical stability chambers and office space at its US Headquarter campus in Souderton, Pennsylvania.
